Dysregulation of the splicing machinery is associated to the development of non-alcoholic fatty liver disease (Supplementary Information).pdf

Supplemental Information from:
Dysregulation of the splicing machinery is associated to the development of non-alcoholic fatty liver disease.
Mercedes del Río-Moreno, MS1,2,3,4, Emilia Alors-Pérez, MS1,2,3,4, Sandra González-Rubio, PhD1,3,5, Gustavo Ferrín, PhD1,3,5, Oscar Reyes, PhD1,6, Manuel Rodríguez-Perálvarez, MD PhD1,3,5, Marina E. Sánchez-Frías, MD PhD1,3,7, Rafael Sánchez-Sánchez, MD1,3,7, Sebastián Ventura, PhD1,6,8, José López-Miranda, MD1,3,4,9, Rhonda D. Kineman, PhD10, Manuel de la Mata, MD1,3,5, Justo P. Castaño, PhD1,2,3,4, Manuel D. Gahete, PhD1,2,3,4*, Raúl M. Luque, PhD1,2,3,4*.
1Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Córdoba, Spain. 2Department of Cell Biology, Physiology and Immunology, University of Córdoba, Córdoba, Spain. 3Reina Sofia University Hospital, Córdoba, Spain. 4CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Córdoba, Spain. 5CIBER Digestive and Liver Diseases (CIBERehd), Córdoba, Spain. 6Department of Computer Sciences, University of Cordoba, Cordoba, Spain. 7Anatomical Pathology Service, Reina Sofia University Hospital (HURS), Cordoba, Spain. 8Department of Information Systems, King Abdulaziz University, Saudi Arabia Kingdom. 9Lipids and Atherosclerosis Unit, Reina Sofia University Hospital, Córdoba, Spain. 10Research and Development Division, Jesse Brown Veterans Affairs Medical Center; Section of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
*These authors should be considered as corresponding authors.